scholarly journals Endoscopy in a COVID-19 Referral National University Hospital: A Single-center Experience and Recommendations

2021 ◽  
Vol 55 (2) ◽  
Author(s):  
John Mark Torres ◽  
Eric Yasay ◽  
Ma. Lourdes Daez ◽  
Mark Anthony De Lusong
Keyword(s):  
University Hospital ◽  
Single Center ◽  
International Guidelines ◽  
Narrative Study ◽  
Endoscopy Unit ◽  
Single Center Experience ◽  
Resource Limited ◽  
Essential Components ◽  
National University ◽  
Set Up

Rationale. COVID-19 pandemic disease, can be transmitted during gastrointestinal procedures, via aerosolized droplets, and via fecal shedding. Both international and local endoscopy societies have issued strategies to alleviate the risk to endoscopy personnel. However, several barriers against the implementation of these recommendations exist thus individual center’s policies are employed whenever applicable. Objectives. This narrative study aims to describe the current experience and set-up in the endoscopy unit of a COVID referral center, discuss the stratification of patients for endoscopy, the operational management of the personnel and endoscopy unit in line with the adapted local and international guidelines and offer endoscopists a quick reference guide to adapt endoscopy practice during the pandemic in a resource-limited setting. Methodology. This paper reviews and consolidates current endoscopy guidelines and describes the single-center experience of Philippine General Hospital. Results. In resource-limited settings, with uncertainties of prolonged COVID-19 impact to healthcare, modification of practice, adherence to strategies and recommendations, empowerment of workforce, establishing the sustainability of resources, training, and service to patients, are essential components to combat current dilemma brought about by this pandemic. Conclusion. Integration of current local and international guidelines encompass all aspects of endoscopy practice during the pandemic. The recommendations cited are aimed to guide other resource-limited endoscopy units for potential changes and guidance in the overall practice.

scholarly journals Low profile REBOA device for increasing systolic blood pressure in hemodynamic instability: single-center 4-year experience of use of ER-REBOA

2021 ◽  
Author(s):  
David T. McGreevy ◽  
Mitra Sadeghi ◽  
Kristofer F. Nilsson ◽  
Tal M. Hörer
Keyword(s):  
Blood Pressure ◽  
Systolic Blood Pressure ◽  
Hemodynamic Instability ◽  
Balloon Occlusion ◽  
University Hospital ◽  
Trauma Patients ◽  
Single Center ◽  
Hemorrhage Control ◽  
Single Center Experience ◽  
Low Profile

Abstract Background Hemodynamic instability due to torso hemorrhage can be managed with the assistance of resuscitative endovascular balloon occlusion of the aorta (REBOA). This is a report of a single-center experience using the ER-REBOA™ catheter for traumatic and non-traumatic cases as an adjunct to hemorrhage control and as part of the EndoVascular resuscitation and Trauma Management (EVTM) concept. The objective of this report is to describe the clinical usage, technical success, results, complications and outcomes of the ER-REBOA™ catheter at Örebro University hospital, a middle-sized university hospital in Europe. Methods Data concerning patients receiving the ER-REBOA™ catheter for any type of hemorrhagic shock and hemodynamic instability at Örebro University hospital in Sweden were collected prospectively from October 2015 to May 2020. Results A total of 24 patients received the ER-REBOA™ catheter (with the intention to use) for traumatic and non-traumatic hemodynamic control; it was used in 22 patients. REBOA was performed or supervised by vascular surgeons using 7–8 Fr sheaths with an anatomic landmark or ultrasound guidance. Systolic blood pressure (SBP) increased significantly from 50 mmHg (0–63) to 95 mmHg (70–121) post REBOA. In this cohort, distal embolization and balloon rupture due to atherosclerosis were reported in one patient and two patients developed renal failure. There were no cases of balloon migration. Overall 30-day survival was 59%, with 45% for trauma patients and 73% for non-traumatic patients. Responders to REBOA had a significantly lower rate of mortality at both 24 h and 30 days. Conclusions Our clinical data and experience show that the ER-REBOA™ catheter can be used for control of hemodynamic instability and to significantly increase SBP in both traumatic and non-traumatic cases, with relatively few complications. Responders to REBOA have a significantly lower rate of mortality.

scholarly journals Liver transplantation: a 10-year single center experience in Pernambuco- northeastern Brazil

2010 ◽  
Vol 13 (2) ◽  
pp. 1288-1292
Author(s):  
Luiz Eduardo C. Miranda ◽  
Paulo Sérgio Vieira de Melo ◽  
Diego Laurentino Lima ◽  
Bernardo Sabat ◽  
Américo Gusmão Amorim ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Survival Curve ◽  
Deceased Donor ◽  
Conventional Technique ◽  
University Hospital ◽  
Northeastern Brazil ◽  
Organ Shortage ◽  
Single Center ◽  
Liver Donor ◽  
Single Center Experience

Purpose: The aim of this study is to analyze a ten-year single center experience in liver transplantation in Pernambuco - Northeastern region of Brazil. Methods: Data were retrospectively collected from medical records of 302 patients who underwent Orthotopic Liver Transplantation (OLT) between 1998 and 2008 at Oswaldo Cruz University Hospital, Pernambuco – Brazil. We analyzed just the outcomes and survival curve of 195 adult liver transplantation recipients from deceased donor. Results: Data concern liver donor, surgery technical aspects and liver transplantation recipients’ postoperative evolution are presented and discussed. This center has a significant experience in liver transplantation using conventional technique with no venovenous bypass. Efficient management of liver transplantation practice has made it feasible to keep the cold ischemia time within 6-7 hours. Because of the organ shortage, we have used a large amount of extended criteria liver donor. The survival 1-year rata was 76.4%. Conclusion: It is possible to provide a high-quality public medical assistance in an efficient and continuous manner in less developed areas of Brazil.

scholarly journals Endoscopy Challenges During the SARS-CoV- 2 Pandemic: A Single-Center Experience from Cairo University Hospital-Egypt

2021 ◽  
Vol 89 (9) ◽  
pp. 1839-1842
Author(s):  
MOHAMED B. HASHEM, M.D.; HEDY A. BADARY, M.D. ◽  
ISMAIL ANWAR, M.D.; SHERIF HAMDY, M.D. ◽  
MOHAMMAD S. ABDELBARY, M.D.; IMAN HAMZA, M.D.
Keyword(s):  
University Hospital ◽  
Single Center ◽  
Single Center Experience

scholarly journals Endosonographic Findings and the Natural Course of Chronic Gastric Anisakiasis: A Single-Center Experience

2018 ◽  
Vol 2018 ◽  
pp. 1-7
Author(s):  
Eun Young Park ◽  
Dong Hoon Baek ◽  
Gwang Ha Kim ◽  
Bong Eun Lee ◽  
So-Jeong Lee ◽  
...  
Keyword(s):  
Muscularis Propria ◽  
University Hospital ◽  
Eosinophil Infiltration ◽  
Tubular Structures ◽  
High Power Field ◽  
Mesenchymal Tumors ◽  
Single Center Experience ◽  
National University ◽  
Raw Fish

Background. Chronic gastric anisakiasis is a rare, usually asymptomatic, and difficult to diagnose infection incidentally discovered during endoscopy, resembling a subepithelial tumor (SET). Because its endoscopic ultrasonography (EUS) findings are not established, it is occasionally misdiagnosed as gastrointestinal mesenchymal tumors and removed by endoscopic or surgical resection. We aimed to assess the characteristic EUS findings of chronic gastric anisakiasis and the clinical course during follow-up. Methods. The database of all patients who underwent EUS at Pusan National University Hospital (Busan, Korea) between January 2011 and December 2016 was retrospectively analyzed. A total of 28 SET cases with EUS features suggesting chronic gastric anisakiasis were included in the study. The EUS, histopathologic, and follow-up endoscopic features were analyzed. Results. On EUS, the lesions were mainly located in the submucosal and/or propria muscle layers. Twenty-seven lesions (27/28, 96%) showed hypoechoic echogenicity, and 22 lesions (22/28, 79%) were heterogeneous. Hyperechoic tubular structures suggesting denaturalized Anisakidae larvae were seen in 22 lesions (22/28, 79%). Endoscopic biopsies revealed significant eosinophil infiltration (≥30 per high-power field) in 12 lesions (12/21, 57%). During the median follow-up period of 9 months (range, 1–55 months), SETs decreased or subsided in 26 lesions (26/28, 93%) with no change in the size of the two lesions (2/28, 7%). Conclusions. Chronic gastric anisakiasis, although rare, should be included in the differential diagnoses for gastric SETs, especially in regions where raw fish is widely consumed. EUS findings suggesting chronic gastric anisakiasis are heterogeneously hypoechoic lesions with hyperechoic tubular structures, mainly in the submucosal and/or muscularis propria layers. Because chronic gastric anisakiasis decreases or subsides in most cases, follow-up endoscopy 6–12 months later is recommended.

Tu1501 Comprehensive Analysis of Efficacy and Safety of POEM Performed in the Endoscopy Unit: a Single Center Experience

2015 ◽  
Vol 81 (5) ◽  
pp. AB487
Author(s):  
Mouen Khashab ◽  
Mohamad H. El Zein ◽  
Sepideh Besharati ◽  
Vivek Kumbhari ◽  
Saowanee Ngamruengphong ◽  
...  
Keyword(s):  
Comprehensive Analysis ◽  
Efficacy And Safety ◽  
Single Center ◽  
Endoscopy Unit ◽  
Single Center Experience

BioBoard

2006 ◽  
Vol 10 (11) ◽  
pp. 578-580
Keyword(s):  
Cancer Research ◽  
Agricultural Biotechnology ◽  
University Hospital ◽  
Research Center ◽  
Children With Cancer ◽  
Research Hospital ◽  
Bird Flu ◽  
International Conference ◽  
National University ◽  
Set Up

Beijing Builds Asia's Largest Biotech Incubator. AstraZeneca to Build a Cancer Research Center in China. Agricultural Biotechnology International Conference in Melbourne. NTU and Mayo Collaborate on Cancer Cure. Bird Flu Deaths in Jakarta. Singapore and India Partner to Study Oral and Throat Cancers. Drug Scandal in China. St. Jude Children's Research Hospital, Singapore's National University Hospital and Viva Foundation to Help Children with Cancer. Novo Nordisk to Set up New Global Patent Unit in India. Vaccine Researcher Critical of CSL and Australian Government's Approach to Bird Flu.

Sign in / Sign up

Export Citation Format

Share Document